title: Comment on serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
authors.forename: Motoh
authors.initials: M
authors.lastname: Iwasa
authors.forename: Rumi
authors.initials: R
authors.lastname: Mifuji-Moroka
authors.forename: Yoshinao
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Takei
authors.forename: Corina
authors.initials: C
authors.lastname: D'Alessandro-Gabazza
authors.forename: Esteban C
authors.initials: EC
authors.lastname: Gabazza
mesh_terms: D005234:Fatty Liver / Q000097:blood* / Q000473:pathology*; D005260:Female; D005346:Fibroblast Growth Factors / Q000097:blood*; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000473:pathology*; D006801:Humans; D008297:Male; D054839:Retinol-Binding Proteins, Plasma / Q000378:metabolism*
chemical_list: D054839:Retinol-Binding Proteins, Plasma; D005346:Fibroblast Growth Factors